• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于免疫疗法和癌症疫苗接种方案:一种数学建模方法。

On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.

机构信息

Department of Mathematics, The Ohio State University, Columbus, OH 43210, USA.

出版信息

J Theor Biol. 2009 Aug 21;259(4):820-7. doi: 10.1016/j.jtbi.2009.05.001. Epub 2009 May 14.

DOI:10.1016/j.jtbi.2009.05.001
PMID:19446568
Abstract

In this paper we develop a new mathematical model of immunotherapy and cancer vaccination, focusing on the role of antigen presentation and co-stimulatory signaling pathways in cancer immunology. We investigate the effect of different cancer vaccination protocols on the well-documented phenomena of cancer dormancy and recurrence, and we provide a possible explanation of why adoptive (i.e. passive) immunotherapy protocols can sometimes actually promote tumour growth instead of inhibiting it (a phenomenon called immunostimulation), as opposed to active vaccination protocols based on tumour-antigen pulsed dendritic cells. Significantly, the results of our computational simulations suggest that elevated numbers of professional antigen presenting cells correlate well with prolonged time periods of cancer dormancy.

摘要

在本文中,我们开发了一种新的免疫治疗和癌症疫苗接种的数学模型,重点研究了抗原呈递和共刺激信号通路在癌症免疫学中的作用。我们研究了不同的癌症疫苗接种方案对癌症休眠和复发的已有文献记载的现象的影响,并对为什么有时采用(即被动)免疫疗法方案实际上可能促进肿瘤生长而不是抑制肿瘤(一种称为免疫刺激的现象),而不是基于肿瘤抗原脉冲树突状细胞的主动疫苗接种方案提供了可能的解释。重要的是,我们的计算模拟结果表明,专业抗原呈递细胞数量的增加与癌症休眠时间的延长密切相关。

相似文献

1
On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.关于免疫疗法和癌症疫苗接种方案:一种数学建模方法。
J Theor Biol. 2009 Aug 21;259(4):820-7. doi: 10.1016/j.jtbi.2009.05.001. Epub 2009 May 14.
2
Optimal control in a model of dendritic cell transfection cancer immunotherapy.树突状细胞转染癌症免疫疗法模型中的最优控制
Bull Math Biol. 2006 Feb;68(2):255-74. doi: 10.1007/s11538-005-9014-3. Epub 2006 Mar 28.
3
Dendritic cells for specific cancer immunotherapy.用于特异性癌症免疫治疗的树突状细胞。
Biol Chem. 2001 Apr;382(4):507-20. doi: 10.1515/BC.2001.065.
4
Dendritic cells in cancer immunotherapy.癌症免疫疗法中的树突状细胞。
Crit Rev Immunol. 2001;21(1-3):133-45.
5
Spinning molecular immunology into successful immunotherapy.将旋转分子免疫学转化为成功的免疫疗法。
Nat Rev Immunol. 2002 Apr;2(4):227-38. doi: 10.1038/nri774.
6
[Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer].[医学实践中的免疫学。第二十五部分。树突状细胞在癌症免疫治疗中的应用]
Ned Tijdschr Geneeskd. 1999 Nov 27;143(48):2408-14.
7
Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.树突状细胞-肿瘤细胞杂交体增强针对小鼠结肠癌的细胞毒性T淋巴细胞诱导:免疫治疗性树突状细胞疫苗接种抗原加载方法的比较分析
Oncol Rep. 2006 Dec;16(6):1317-24.
8
Quality and quantity: new strategies to improve immunotherapy of cancer.质量与数量:改善癌症免疫疗法的新策略
Trends Mol Med. 2004 May;10(5):205-8. doi: 10.1016/j.molmed.2004.03.004.
9
Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.树突状细胞的抗原呈递及其在抗肿瘤免疫治疗中的意义。
In Vivo. 2004 Jan-Feb;18(1):81-100.
10
Immunotherapy of cancer using dendritic cells.使用树突状细胞进行癌症免疫治疗。
Cytokines Cell Mol Ther. 1998 Mar;4(1):35-44.

引用本文的文献

1
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in Melanomas.优化黑色素瘤疫苗诱导免疫疗法的疗效
Bull Math Biol. 2025 May 28;87(7):86. doi: 10.1007/s11538-025-01462-w.
2
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in Melanomas.优化黑色素瘤疫苗诱导免疫疗法的疗效
bioRxiv. 2025 Jan 8:2025.01.06.631283. doi: 10.1101/2025.01.06.631283.
3
Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.针对乳腺癌的 BET 和免疫检查点抑制剂联合治疗的建模。
Proc Natl Acad Sci U S A. 2018 May 22;115(21):5534-5539. doi: 10.1073/pnas.1721559115. Epub 2018 May 7.
4
Rosmarinic Acid Activates AMPK to Inhibit Metastasis of Colorectal Cancer.迷迭香酸激活AMPK以抑制结直肠癌转移。
Front Pharmacol. 2018 Feb 5;9:68. doi: 10.3389/fphar.2018.00068. eCollection 2018.
5
Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.用数学和计算建模应对癌症免疫治疗中的当前挑战。
J R Soc Interface. 2017 Jun;14(131). doi: 10.1098/rsif.2017.0150.
6
Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation.模拟癌症免疫反应的二分法:细胞毒性作用与肿瘤促进炎症
Bull Math Biol. 2017 Jun;79(6):1426-1448. doi: 10.1007/s11538-017-0291-4. Epub 2017 Jun 5.
7
Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model.癌症疫苗与免疫检查点抑制剂联合治疗癌症:一个数学模型。
PLoS One. 2017 May 25;12(5):e0178479. doi: 10.1371/journal.pone.0178479. eCollection 2017.
8
On Study of Immune Response to Tumor Cells in Prey-Predator System.捕食-被捕食系统中肿瘤细胞免疫反应的研究
Int Sch Res Notices. 2014 Sep 22;2014:346597. doi: 10.1155/2014/346597. eCollection 2014.
9
A cancer treatment based on synergy between anti-angiogenic and immune cell therapies.一种基于抗血管生成与免疫细胞疗法协同作用的癌症治疗方法。
J Theor Biol. 2016 Apr 7;394:197-211. doi: 10.1016/j.jtbi.2016.01.026. Epub 2016 Jan 27.
10
Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control.具有化学免疫疗法和最优控制的肿瘤免疫反应延迟微分模型
Comput Math Methods Med. 2014;2014:982978. doi: 10.1155/2014/982978. Epub 2014 Aug 14.